HOME / PUBLICATIONS /

Publications

2020
Aouag S, Kadri S, HEDJAZI D. Towards architectural view-driven modernization. 2020 International Conference on Advanced Aspects of Software Engineering (ICAASE). 2020 :1-6.
Aouag S, Kadri S, HEDJAZI D. Towards architectural view-driven modernization. 2020 International Conference on Advanced Aspects of Software Engineering (ICAASE). 2020 :1-6.
Aouag S, Kadri S, HEDJAZI D. Towards architectural view-driven modernization. 2020 International Conference on Advanced Aspects of Software Engineering (ICAASE). 2020 :1-6.
Morabito F, Gentile M, Monti P, Recchia AG, Menichini P, Skafi M, Atrash M, De Luca G, Bossio S, Al-Janazreh H. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert Opinion on Investigational DrugsExpert Opinion on Investigational Drugs. 2020;29 :869-880.
Morabito F, Gentile M, Monti P, Recchia AG, Menichini P, Skafi M, Atrash M, De Luca G, Bossio S, Al-Janazreh H. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert Opinion on Investigational DrugsExpert Opinion on Investigational Drugs. 2020;29 :869-880.
Morabito F, Gentile M, Monti P, Recchia AG, Menichini P, Skafi M, Atrash M, De Luca G, Bossio S, Al-Janazreh H. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert Opinion on Investigational DrugsExpert Opinion on Investigational Drugs. 2020;29 :869-880.
Morabito F, Gentile M, Monti P, Recchia AG, Menichini P, Skafi M, Atrash M, De Luca G, Bossio S, Al-Janazreh H. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert Opinion on Investigational DrugsExpert Opinion on Investigational Drugs. 2020;29 :869-880.
Morabito F, Gentile M, Monti P, Recchia AG, Menichini P, Skafi M, Atrash M, De Luca G, Bossio S, Al-Janazreh H. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert Opinion on Investigational DrugsExpert Opinion on Investigational Drugs. 2020;29 :869-880.
Morabito F, Gentile M, Monti P, Recchia AG, Menichini P, Skafi M, Atrash M, De Luca G, Bossio S, Al-Janazreh H. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert Opinion on Investigational DrugsExpert Opinion on Investigational Drugs. 2020;29 :869-880.
Morabito F, Gentile M, Monti P, Recchia AG, Menichini P, Skafi M, Atrash M, De Luca G, Bossio S, Al-Janazreh H. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert Opinion on Investigational DrugsExpert Opinion on Investigational Drugs. 2020;29 :869-880.
Morabito F, Gentile M, Monti P, Recchia AG, Menichini P, Skafi M, Atrash M, De Luca G, Bossio S, Al-Janazreh H. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert Opinion on Investigational DrugsExpert Opinion on Investigational Drugs. 2020;29 :869-880.
Morabito F, Gentile M, Monti P, Recchia AG, Menichini P, Skafi M, Atrash M, De Luca G, Bossio S, Al-Janazreh H. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert Opinion on Investigational DrugsExpert Opinion on Investigational Drugs. 2020;29 :869-880.
Morabito F, Gentile M, Monti P, Recchia AG, Menichini P, Skafi M, Atrash M, De Luca G, Bossio S, Al-Janazreh H. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert Opinion on Investigational DrugsExpert Opinion on Investigational Drugs. 2020;29 :869-880.
Benreguia B, Moumen H, Merzoug MA. Tracking covid-19 by tracking infectious trajectories. Ieee AccessIEEE Access. 2020;8 :145242-145255.
Benreguia B, Moumen H, Merzoug MA. Tracking covid-19 by tracking infectious trajectories. Ieee AccessIEEE Access. 2020;8 :145242-145255.
Benreguia B, Moumen H, Merzoug MA. Tracking covid-19 by tracking infectious trajectories. Ieee AccessIEEE Access. 2020;8 :145242-145255.
Saidi A, Naceri F, Youb L, Cernat M, Pesquer LG. Two types of fuzzy logic controllers for the speed control of the doubly-fed induction machine. Advances in Electrical and Computer EngineeringAdvances in Electrical and Computer Engineering. 2020;20 :65-74.
Saidi A, Naceri F, Youb L, Cernat M, Pesquer LG. Two types of fuzzy logic controllers for the speed control of the doubly-fed induction machine. Advances in Electrical and Computer EngineeringAdvances in Electrical and Computer Engineering. 2020;20 :65-74.
Saidi A, Naceri F, Youb L, Cernat M, Pesquer LG. Two types of fuzzy logic controllers for the speed control of the doubly-fed induction machine. Advances in Electrical and Computer EngineeringAdvances in Electrical and Computer Engineering. 2020;20 :65-74.
Saidi A, Naceri F, Youb L, Cernat M, Pesquer LG. Two types of fuzzy logic controllers for the speed control of the doubly-fed induction machine. Advances in Electrical and Computer EngineeringAdvances in Electrical and Computer Engineering. 2020;20 :65-74.

Pages